Dr. Carlos U. Corvera

Adnan Alseidi is a Surgical Oncologist practicing medicine in San Francisco, California. Dr. Alseidi is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Pancreatic Ductal Adenocarcinoma, Pancreaticoduodenectomy, and Gallbladder Removal. Dr. Alseidi is currently accepting new patients.

Dr. Eric Nakakura is a cancer surgeon who specializes in tumors of the liver, pancreas, bile ducts and gastrointestinal tract. He also treats soft tissue sarcomas, including tumors of the retroperitoneum (a space in the abdominal cavity), trunk and extremities. At the UCSF Helen Diller Family Comprehensive Cancer Center, he helps manage complex gastrointestinal tract cancers, soft tissue sarcomas and gastrointestinal neuroendocrine tumors, including carcinoid and islet cell tumors. In his research, Nakakura studies endocrine differentiation in gastrointestinal tumors. Nakakura earned his medical degree at Stanford University School of Medicine. He earned a doctorate in cellular and molecular medicine at Johns Hopkins University. He completed a residency in general surgery at Johns Hopkins Medicine and received advanced training in surgery at the John Radcliffe Hospital in Oxford, England. At Johns Hopkins, he completed a fellowship in surgical oncology with an emphasis on pancreatic, biliary and gastrointestinal surgery. Dr. Nakakura is highly rated in 35 conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Pancreatic Cancer, Retroperitoneal Liposarcoma, Pancreatectomy, and Pancreaticoduodenectomy. Dr. Nakakura is board certified in American Board Of Surgery, General Surgery. Dr. Nakakura is currently accepting new patients.

Dr. Kenzo Hirose is a surgeon who cares for patients with benign or cancerous conditions affecting the liver, pancreas and bile ducts. He has expertise in using minimally invasive surgical techniques, which are generally safer and cause less post-op pain than traditional surgery. In his research, Hirose is interested in improving patient outcomes after surgery. Hirose earned his medical degree at Harvard Medical School. He completed a residency in general surgery at UCSF and a fellowship in liver, pancreatic and biliary tract surgery at the Cleveland Clinic. Dr. Hirose is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Neuroendocrine Tumor, Pancreatectomy, and Pancreaticoduodenectomy. Dr. Hirose is board certified in American Board Of Surgery, General Surgery. Dr. Hirose is currently accepting new patients.